phone icon  Int'l : +1-503-894-6022
Allied Market Research
0
Shopping Cart is Empty..
$ 0

DNA diagnostics is a cutting edge method which is set to revolutionize the field of medical diagnostics. This technique enables medical professionals to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same. It is also used for clinical diagnostic confirmation and in prenatal diagnostics. The concept of DNA diagnostics has evolved via the breakthrough human genome project that resulted in the discovery of various disease-causing agents. The DNA diagnostics market is expected to generate 19 billion by 2020, growing at a CAGR of 9.8% during the analysis period. Technological development has played a major role in improving DNA diagnostic platforms and techniques.

Some of the significant technologies which incorporate DNA diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology and mass spectrometry; these technologies are used for sample preparation, DNA isolation etc. Technological developments, which have led to improvements in these methodologies, drive the growth of the DNA diagnostics market. The use of DNA diagnostic methods in prenatal diagnostics and clinical confirmation has also boosted market growth. The DNA diagnostics market is expected to experience a growth spurt in the foreseeable future. Innovations in product design and technology have prompted doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines. The increased adoption of the personalized medicines approach would positively impact the DNA diagnostics market in the foreseeable future. Next generation sequencing is a powerful tool for decoding a number of human diseases, including various forms of cancer. Next generation sequencing reduces the cost of sequencing and increases the throughput. The optimization of sequencing technology could greatly impact the DNA diagnostics market.

The report breaks the market into segments based on product type, technology, application, end users and geography. Based on product types, the market is segmented into instruments, reagents and service & software. The instruments segment holds the dominant share in the market, due to improved healthcare facilities, availability of user-friendly instruments, its competitive cost structure, reliability, size and the growing demand for it in the DNA diagnostics market. However, the service & software segment is expected to grow at a steady rate in the near future due to technological advancements and the incorporation of information technology in the DNA diagnostics market. There are several technologies used in the DNA diagnostics market; these include PCR, mass spectrometry, sequencing technology, in-situ hybridization and microarrays. PCR holds the dominant share due to its frequent usage in diagnostic procedures such as sample preparation, separation and isolation of DNA from collected samples. The DNA diagnostics market is also segmented based on its application in various diseases such as oncology, infectious diseases and myogenic disorders. The oncology segment leads the market and is followed by infectious diseases due to the rising incidence of these diseases and growing elderly population. In terms of geography, the market is segmented into North America, Asia Pacific, Europe and LAMEA. North America holds the dominant share in the market due to the increased adoption of the DNA diagnostics technology and the high prevalence of chronic and infectious diseases. Companies profiled in the report include Roche Diagnostics, Bayer Diagnostic, Sysmex, Abbott laboratories, Gene-probe Inc., Cephide, Illumina, Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Johnson and Johnson, and Novartis.

Global DNA Diagnostics Market

KEY BENEFITS

  • An in-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans
  • The report studies the application of next generation sequencing technology and biotechnology and their impact on the DNA diagnostics market
  • A comprehensive analysis of the factors that drive and restrict the growth of the DNA diagnostics market is provided
  • Key regulatory guidelines in various regions which impact the DNA diagnostics market are critically examined
  • A quantitative analysis of the current market and estimations through 2013-2020 are provided to showcase the financial caliber of the DNA diagnostics market
  • Detailed analysis of the Asia-pacific region provides insights that would enable companies to plan their business move strategically
  • Value chain analysis in the report gives a clear understanding of the roles of the stakeholders involved in the supply chain of the DNA diagnostics market

MARKET SEGMENTATION:

The DNA diagnostics market is segmented based on product type, technology, application, end users and geography

MARKET BY PRODUCT TYPE

  • Instruments
  • Reagents
  • Service & Software

MARKET BY TECHNOLOGY

  • PCR
  • Microarray
  • In-situ Hybridization
  • Sequencing Technology
  • Mass Spectrometry
  • Others

MARKET BY APPLICATION

  • Oncology
    • Prostate Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Others
  • Infectious Disease
    • Hepatitis B Virus
    • Hepatitis C Virus
    • HIV
    • TB
    • Chlamydia Trachomatic and Neisseria Gonorrhea (CT/NG)
    • HPV
    • Methiciline Resistant Staphylococcus Aureus (MRSA)
    • Others
  • Myogenic Disorder
  • Clinical Diagnostic Confirmation
  • Prenatal Diagnostics
  • Pre-implantation Diagnostics
  • Others

MARKET BY END USERS

  • Point of Care
  • Diagnostic Center
  • Self Testing/OTC

MARKET BY GEOGRAPHY

  • North America
  • Asia Pacific
  • Europe
  • LAMEA

* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com
Title/ Chapter Name

Chapter: 1 INTRODUCTION

1.1 Report Description
1.2 Reason for doing the study

1.2.1 Key Benefits
1.2.2 Key Market Segments
1.2.3 Key Audiences

1.3 Research Methodology

1.3.1 Secondary Research
1.3.2 Primary Research
1.3.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($Million)

2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Application of biotechnology in DNA Diagnostic
3.3 Responsibility of Next-generation Sequencing technologies
3.4 Key Findings

3.4.1 Top Factors Impacting on DNA Diagnostics market
3.4.2 Top Investment Pockets of DNA Diagnostics market
3.4.3 Top winning strategies of DNA Diagnostics market

3.5 Government Regulations

3.5.1 FDA guidelines for personalized medicines

3.6 P orter’s Five force Analysis

3.6.1 Bargaining power of suppliers
3.6.2 Bargaining power of Buyers
3.6.3 Threat from new entrants
3.6.4 Threat of Substitute
3.6.5 Competitive Rivalry

3.7 Value chain analysis

3.7.1 Primary Activities
3.7.2 Supportive activities

3.8 Clinical Trials
3.9 Patent Analysis

3.9.1 Patent analysis by geographies(2010-2014)
3.9.2 Patent analysis by sub-segment (2010-2014)

3.10 Market Share Analysis,2013
3.11 Market Dynamics

3.11.1 Drivers

3.11.1.1 Increasing incidences of chronic and infectious diseases
3.11.1.2 Technological Advancements and product modification
3.11.1.3 Increase in popularity personalized medicine approach

3.11.2 Restraints

3.11.2.1 High cost involved in reaseach & development
3.11.2.2 Unclear reimbursement policies&stringent government regulation

3.11.3 Opportunities

3.11.3.1 Technological Development
3.11.3.2 Increasing need of Personalized Medicines

Chapter: 4 GLOBAL DNA DIAGNOSTICS MARKET BY PRODUCT TYPES

4.1 Instruments

4.1.1 Key market trends
4.1.2 Competitive Scenario
4.1.3 Key growth factors and opportunities
4.1.4 Market size and forecast

4.2 Reagents

4.2.1 Key market trends
4.2.2 Competitive Scenario
4.2.1 Key growth factors and opportunities
4.2.2 Market size and forecast

4.3 Software & Services

4.3.1 Key market trends
4.3.1 Competitive Scenario
4.3.1 Key growth factors and opportunities
4.3.2 Market size and forecast

Chapter: 5 GLOBAL DNA DIAGNOSTICS MARKET BY TECHNOLOGY, 2013-2020

5.1 PCR

5.1.1 Key market trends
5.1.2 Competitive scenario
5.1.3 Key growth factors and opportunities
5.1.4 Market size and forecast

5.2 Microarrays

5.2.1 Lab on chip
5.2.2 DNA microarray
5.2.3 Protein microarray
5.2.4 Key market trends
5.2.5 Competitive scenario
5.2.6 Key growth factors and opportunities
5.2.7 Market size and forecast

5.3 In situ hybridization

5.3.1 Key market trends
5.3.2 Competitive scenario
5.3.3 Key growth factors and opportunities
5.3.4 Market size and forecast

5.4 Sequencing Technology

5.4.1 Key market trends
5.4.2 Competitive scenario
5.4.3 Key growth factors and opportunities
5.4.4 Market size and forecast

5.5 Mass Spectrometry

5.5.1 Key market trends
5.5.2 Competitive scenario
5.5.3 Key growth factors and opportunities
5.5.4 Market size and forecast

5.6 Others

5.6.1 Key market trends
5.6.2 Competitive scenario
5.6.3 Key growth factors and opportunities
5.6.4 Market size and forecast

Chapter: 6 GLOBAL DNA DIAGNOSTICS MARKET BY APPLICATIONS, 2013-2020

6.1 Oncology

6.1.1 Prostate Cancer
6.1.2 Breast Cancer
6.1.3 Colorectal Cancer
6.1.4 Others

6.2 Infectious disease testing

6.2.1 Hepatitis B Virus (HBV)
6.2.2 Hepatitis C Virus (HCV)
6.2.3 Human Immunodeficiency Virus (HIV)
6.2.4 Tuberculosis (TB)
6.2.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.6 Human Papillomavirus (HPV)
6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.8 Others

6.3 Myogenic disorder diagnosis
6.4 Clinical diagnosis confirmation
6.5 Prenatal diagnosis
6.6 Pre-implantation diagnosis
6.7 Others

Chapter: 7 GLOBAL DNA DIAGNOSTIC MARKET BY END-USERS, 2013-2020

7.1 Point of Care
7.2 Central Laboratories/Diagnostic Centers
7.3 Self Testing/OTC

Chapter: 8 GLOBAL DNA DIAGNOSTIC MARKET BY GEOGRAPHY, 2013-2020

8.1 North America

8.1.1 Key market trends
8.1.2 Competitive scenario
8.1.3 Key growth factors and opportunities
8.1.4 Market size and forecast
8.1.5 United States
8.1.6 Canada
8.1.7 Mexico

8.2 Europe

8.2.1 Key market trends
8.2.2 Competitive scenario
8.2.3 Key growth factors and opportunities
8.2.4 Market size and forecast
8.2.5 France
8.2.6 Germany
8.2.7 United Kingdom
8.2.8 Others

8.3 Asia-Pacific

8.3.1 Key market trends
8.3.2 Competitive scenario
8.3.3 Key growth factors and opportunities
8.3.4 Market size and forecast

8.4 LAMEA

8.4.1 Key market trends
8.4.2 Competitive scenario
8.4.3 Key growth factors and opportunities
8.4.4 Market size and forecast
8.4.5 Latin America
8.4.6 Middle East
8.4.7 Africa

Chapter: 9 ASIA PACIFIC DNA DIAGNOSTIC MARKET ANALYSIS 2013-2020

9.1 Market dynamics
9.2 Key market trends
9.3 Clinical trials
9.4 Government regulations
9.5 Company analysis by region

9.5.1 India

9.5.1.1 Genome Diagnostics Pvt. Ltd.
9.5.1.2 Transasia
9.5.1.3 Dr Reddy’s lab

9.5.2 china
9.5.3 Australia

9.5.3.1 Genera biosystems

9.5.4 Japan

9.5.4.1 Sysmex

Chapter: 10 COMPANY PROFILES

10.1 Sysmex

10.1.1 Company Overview
10.1.2 Company Snapshot
10.1.3 Financial performance
10.1.4 Strategic moves and developments

10.1.4.1 Primary Strategy: product launch
10.1.4.2 secondary Strategy: collaboration and partnership

10.1.5 SWOT analysis

10.2 Bayer Diagnostic

10.2.1 Overview
10.2.2 Company snapshot
10.2.3 Financial performance
10.2.4 Strategic moves and developments

10.2.4.1 Primary Strategy: product launch

10.2.5 SWOT analysis

10.3 Roche Diagnostics

10.3.1 Overview
10.3.2 Company snapshot
10.3.3 Financial performance
10.3.4 Strategic moves and developments

10.3.4.1 Primary Strategies:product launch
10.3.4.2 Secondary Strategy: Collaboration

10.3.5 SWOT analysis

10.4 Abbott Laboratories

10.4.1 Overview
10.4.2 Company snapshot
10.4.3 Financial performance
10.4.4 Strategic moves and developments

10.4.4.1 Primary Strategies: product launch

10.4.5 SWOT analysis

10.5 Cephide Inc.

10.5.1 Overview
10.5.2 Company snapshot
10.5.3 Financial performance
10.5.4 Strategic moves and developments

10.5.4.1 Primary Strategies: partnership and product launch
10.5.4.2 Secondary Strategy: Collaboration

10.5.5 SWOT analysis

10.6 Gen-probe Inc. (Hologic)

10.6.1 Overview
10.6.2 Company snapshot
10.6.3 Financial performance
10.6.4 Strategic moves and developments

10.6.4.1 Primary Strategy: product launch

10.6.5 SWOT analysis

10.7 Illumina, Inc.

10.7.1 Overview
10.7.2 Company snapshot
10.7.3 Financial performance
10.7.4 Strategic moves and developments

10.7.4.1 Primary Strategies: partnership and product launch

10.7.5 SWOT analysis

10.8 Thermo Fisher Scientific

10.8.1 Overview
10.8.2 Company snapshot
10.8.3 Financial performance
10.8.4 Strategic moves and developments

10.8.4.1 Primary Strategies:product launch
10.8.4.2 Secondary Strategy: Collaborationand acquisition

10.8.5 SWOT analysis

10.9 Bio-Rad Laboratories

10.9.1 Overview
10.9.2 Company snapshot
10.9.3 Financial performance
10.9.4 Strategic moves and developments

10.9.4.1 Primary Strategies: product launch
10.9.4.2 Secondary Strategies: Acquistaion

10.9.5 SWOT analysis

10.10 Johnson and Johnson

10.10.1 Overview
10.10.2 Company snapshot
10.10.3 Financial performance
10.10.4 Strategic moves and developments

10.10.4.1 Primary strategies: collaboration

10.10.5 SWOT analysis

10.11 Novartis

10.11.1 Overview
10.11.2 Company snapshot
10.11.3 Financial performance
10.11.4 Strategic moves and developments

10.11.4.1 Primary Strategies: product launch
10.11.4.2 secondary Strategies: collaboration and partnership

10.11.5 SWOT analysis

LIST OF TABLES

TABLE 1  Dna diagnostic market moderate growth scenario by geography, 2020-2025 ($Million)
TABLE 2  Dna diagnostic market rapid growth scenario by geography, 2020-2025 ($Million)
TABLE 3  Dna diagnostic market diminishing growth scenario by geography, 2020-2025 ($Million)
TABLE 4  Milestone of FDA guidelines for personalized medicines
TABLE 5  Clinical trials conducted for DNA diagnostics technologies
TABLE 6  Chronic Disease Prevalence
TABLE 7  Types of DNA diagnostic devices by technology
TABLE 8  Global dna diagnostic market revenue by product types, 2013-2020 ($Million)
TABLE 9  Global Instrument dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 10  Global reagents dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 11  Global software & services dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 12  Global dna diagnostic market revenue by technology 2013-2020 ($Million)
TABLE 13  Global PCR technology market revenue by geography:  2020-2025 ($Million)
TABLE 14  Microarray technology pricing chart
TABLE 15  Global Microarray technology market revenue by geography, 2013-2020 ($Million)
TABLE 16  In situ hybridization devices pricing chart
TABLE 17  Global In situ hybridization technology market revenue by geography, 2013-2020 ($Million)
TABLE 18  Global sequencing technology market revenue by market revenue by geography,  2013-2020 ($Million)
TABLE 19  laboratory equipment prices
TABLE 20  Global mass spectrometry market revenue by geography,  2013-2020 ($Million)
TABLE 21  Global other technology market revenue by geography,  2013-2020 ($Million)
TABLE 22  Global dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 23  Global oncology dna diagnostic application market revenue by geography,  2013-2020 ($Million)
TABLE 24  Global Infectious diseases dna diagnostic application market revenue by geography,  2013-2020 ($Million)
TABLE 25  Global Myogenic disorder dna diagnostic application market revenue by geography,  2013-2020 ($Million)
TABLE 26  Global Clinical dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 27  Global Prenatal dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 28  Global Per-implantation dna diagnostic application market revenue by geography,  2013-2020 ($Million)
TABLE 29  Other dna diagnostic application market revenue by geography,  2013-2020 ($Million)
TABLE 30  Global dna diagnostic market revenue by end users:  2013-2020 ($Million)
TABLE 31  Global point of care dna diagnostic market revenue by geography,  2013-2020 ($Million)
TABLE 32  Global diagnostic center  dna diagnostic market revenue by geography,  2013-2020 ($Million)
TABLE 33  Global Self testing/OTC dna diagnostic market revenue by geography,  2013-2020 ($Million)
TABLE 34  United states dna diagnostics market revenue by application, 2013-2020 ($ million)
TABLE 35  Canada dna diagnostic market revenue by application, 2013-2020 ($ million)
TABLE 36  Mexico dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 37  France dna diagnostic market revenue by application,  2013-2020 ($Million)
TABLE 38  Germany dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 39  United kingdom dna diagnostic market revenue by application,  2013-2020 ($Million)
TABLE 40  Others  dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 41  Asia pacific dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 42  lamea dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 43  LAtin america dna diagnostic market revenue by application,  2013-2020 ($Million)
TABLE 44  Middle east dna diagnostic market revenue by application,  2013-2020 ($Million)
TABLE 45  Africa dna diagnostic market revenue by application,  2013-2020 ($Million)
TABLE 46  Company snapshot of Sysmex
TABLE 47  Company snapshot of Bayer Diagnostic
TABLE 48  Company snapshot of Roche DIAGNOSTICS
TABLE 49  Company snapshot of Abbott Laboratories
TABLE 50  Company snapshot Cephide inc
TABLE 51  Company snapshot of Gen-probe Inc. (Hologic)
TABLE 52  Company snapshot of Illumina, Inc.
TABLE 53  Company snapshot of Thermo Fisher Scientific
TABLE 54  Company snapshot of Bio-Rad Laboratories
TABLE 55  Company snapshot of Johnson & Johnson
TABLE 56  Company snapshot of Novartis

LIST OF FIGURES

FIG.1  Top Factors Impacting on DNA Diagnostics market
FIG.2  Top Investment Pockets of DNA Diagnostics market
FIG.3  Top winning strategies for DNA diagnostic market during 2010-2014
FIG.4  Recent development of DNA diagnostic market by companies (2010-2014)
FIG.5  Top wining strategies by subtype of developments
FIG.6  Porter’s Five force Analysis of DNA DIagnostics market
FIG.7  Value chain analysis of Dna diagnostics market
FIG.8  Patent analysis by geographies (2010-2014)
FIG.9  Patent analysis of Sub Segment(2010-2014)
FIG.10  Market share analysis of DNA diagnostics market
FIG.11  Factors affecting the commercial potential of companies developing a molecular diagnostic
FIG.12  Net sales by geographic region (2013)
FIG.13  SWOT analysis of sysmex
FIG.14  Revenue generated
FIG.15  Revenue generation by segments
FIG.16  Swot analysis of Bayer
FIG.17  Net diagnostic sales by geography (2013)
FIG.18  SWOT analysis of roche Diagnostics
FIG.19  Net revenue generation by abbott (2012-2013)
FIG.20  Net revenue generation by segments  (2013)
FIG.21  SWOT analysis of abbott LABORATORIES
FIG.22  Net sales by geography (2013)
FIG.23  Net sales by clinical and non clinical market(2013)
FIG.24  SWOT analysis of cepheid inc.
FIG.25  Revenue generated  by the company in 2011 and 2012
FIG.26  SWOT analysis of Gen-probe Inc. (Hologic)
FIG.27  Net revenue generation (2012-2013)
FIG.28  SWOT analysis of ILLUMINA, INC.
FIG.29  Net sales by segments (2013)
FIG.30  Revenue  generation (2011-2013)
FIG.31  Revenue genetaration by segments (2013)
FIG.32  Swot analysis of Thermo Fisher Scientific
FIG.33  Net revenue generation (2011-2013)
FIG.34  Net sales by segments (2013)
FIG.35  Net sales by geogrephy (2013)
FIG.36  SWOT analysis of bio-rad laboratories
FIG.37  Revenue generation by Segment (2013)
FIG.38  Revenues generation by Geography (2013)
FIG.39  SWOT analysis of johnson & johnson
FIG.40  Net revenue generation by geography (2013)
FIG.41  Net revenue generation by businesses (2013)
FIG.42  SWOT analysis of Novartis

The global DNA diagnostic market is expected to grow at healthy rate during the forecast period. The adoption of new technology such as next generation sequencing, polymerase chain reaction and microarray are primarily driving the DNA diagnostic market. The global DNA diagnostic market in this report is segmented based on the technology, application and end users.  Several diagnostic companies are exploiting the lucrative opportunities available in this market. DNA diagnostics is being used in several applications such as diagnosis of infectious diseases, oncology/cancer, myogenic disorders, prenatal diagnostics and pre-implantation diagnostics etc. The DNA diagnostics market has numerous opportunities in developed and developing economies due to increasing awareness amongst the public about healthcare, cost effective diagnostic solutions and accurate and faster test results. Demand for DNA diagnostic methods in developed economies would gain popularity in near future, as the consumer base in these countries shows an inclination towards effective diagnostic treatment instead of traditional medication; hence, the DNA diagnostic market is expecting sluggish growth in developed countries during the analysis period.

SINGLE USER
GROUP LICENSE
SITE LICENSE
GLOBAL LICENSE
$4515
$5325
$7350
$10680
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Limited to 5 authorized users

Up to 25 users


unlimited within company / enterprise
Copy/Paste
Allowed up to 20% of the content
Allowed up to 25% of the content
Allowed up to 50% of the content
allowed 100%

Printing
One print only

Five Prints

Unlimited for internal use
Unlimited for internal use
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Single User
$4515
Group User
$5325
Site User
$7350
Global User
$10680
buy now

Discount will be applied in cart.
First time buyer ?
Check offers and discount
on this report
GET DISCOUNT
Need More Information
phone_n +1-503-894-6022

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    Flow cytometry is a biophysical, laser based analytical technology that measures and analyses several physical characteristics of cells or particles suspended in a fluid, when passed through a laser beam.
    Oct 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Neuroprosthetics, also referred to as neural implants/brain implants, have gained significant momentum during past few years owing to the immense potential to substitute and/or ameliorate any damaged sensory, motor or cognitive functions. Such Neuroprosthetics are the key to restore and/or augment the ‘quality-of-life’ of the affected patient populace.
    Nov 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    The bioinformatics market is expected to grow to $12.86 billion by 2020 with a CAGR of 21.2% during 2014-2020. Bioinformatics is an interdisciplinary field that is used in the development and storage of data, thus helping in the analysis, organization and retrieval of the biological data. Bioinformatics has various applications and thus forms part of almost all the fields in biology. Bioinformatics form a part of agriculture, animal breeding, molecular medicine, preventive medicine, etc. The major factors driving the bioinformatics market is the need for integrated data, rising demand for drug development and discovery, the increasing focus in genomics & proteomics and the favorable government initiatives.
    May 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    The global medical automation technologies market provides various automated services in health monitoring, prescriptions, therapeutics etc. The global medical technologies market revenue stood at $300 billion in 2011 and it is expected to grow at a CAGR of 7% by 2016. The medical automation technologies market is expected to have a significant market share as highly automated and sophisticated services are available in the market. Venture capitalists are investing in the market to boost the development of medical automation, which is a key driver for the market.
    Jul 2016 | View Details >>
  • ...
    Biosensors are integrated medical devices that provide analytical information by using the given biological samples in micro-volumes. The biosensors comprise of three major components, which include the biological recognition unit, bio elements, and transducers.
    Jul 2016 | View Details >>
  • ...
    Electro surgeries, which are known and preferred for their less invasiveness, faster recovery, and low risk, are mainly dependent on various electrosurgical devices for its efficiency. Recently, with the development of technology, many new types of electrosurgical devices have been introduced in the market. The increasing demand of minimally invasive techniques, increasing geriatric populations and rapidly increasing adoption rate in developing regions are the key factors, which would drive the growth of electrosurgical devices market during the analysis period.
    Jul 2016 | View Details >>
  • ...
    Magnetic Resonance Imaging (MRI) is a technique used in radiology to capture images of physiological processes in body. Closed MRI system is a tube-like tunnel with high field strength used to obtain greater resolution and thinner slices. It is helpful to study smaller parts of body. It scans patients faster than other MRI systems. Closed MRI systems use magnetic field and radio waves that screen and diagnose various diseases, such as multiple sclerosis (MS), cartilage degeneration in the knee, breast cancer, dementia, prostate cancer, spinal tuberculosis, and others.
    Jul 2016 | View Details >>